Pertussis vaccines: Acellular versus whole-cell

Medical Journal of Australia

Volumn 164, Issue 9, 1996, Pages 564-566

  Boughton, Clement R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HEMAGGLUTININ; OUTER MEMBRANE PROTEIN; PERTUSSIS VACCINE; TOXOID;

ADVERSE DRUG REACTION; AUSTRALIA; BORDETELLA PERTUSSIS; DRUG EFFICACY; LICENCE; PERTUSSIS; SHORT SURVEY;

EID: 0029864141     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb122176.x     Document Type: Short Survey

References (21)

1. World Health Organization Diphtheria epidemic - new independent states of the former Soviet Union 1990-1994 MMWR Morb Mortal Wkly Rep 1995, 44 177-181.
2. Schmitt HJ, von Konig CH, Neiss A, et al Efficacy of acellular pertussis vaccine in early childhood after household exposure JAMA 1996, 275 37-41
3. Gustafsson L, Hallander HO, Olin P, et al A controlled trial of a two-component acellular, a five-component acellular, and a whole cell pertussis vaccine. N Engl J Med 1996, 334 349-355
4. Greco D, Salmaso S, Mastrantonio P, et al A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis N Engl J Med 1996, 334 341-348.
5. Onorato IM, Wassilak SG, Wade B Efficacy of whole cell pertussis vaccine in preschool children in the United States JAMA 1992; 267 2745-2749
6. Scheifele DW, Meekison W, Guasparini R, et al. Can reductions in diphtheria toxoid or aluminium content reduce the reactogenicity of booster doses of DPT vaccine? Immunol Infect Dis 1995; 5: 73-77
7. Feery BJ Incidence and type of reactions to triple antigen (DTP) and DT (CDT) vaccines Med J Aust 1982, 2 511-515.
8. Cody CL, Baraff LJ, Cherry JD, et al. Nature and rates of adverse reactions associated with DTP and DT immunisations in infants and children Pediatrics 1981, 68 650-660
9. Edwards KM. Acellular pertussis vaccines - a solution to the pertussis problem? J Infect Dis 1993, 168 15-20.
10. Harris G, Molan T, Hartman L Clinical signs associated with triple antigen (DTP) vaccination in infants J Paediatr Child Health 1995, 31: 228-232.
11. Feery BJ, Boughton CR The evidence in favour of immunisation - a world without smallpox - a world without polio Med J Aust 1994, 160: 459-460
12. Centers for Disease Control Pertussis - England and Wales. MMWR Morb Mortal Wkly Rep 1982; 31 629-632
13. Pollard R. Relation between vaccination and notification rates for whooping cough in England and Wales. Lancet 1980, 1: 1180-1182
14. Galbraith NS, Forbes P, Mayon-White RT Changing patterns of communicable disease in England and Wales Part III - Increasing infectious diseases BMJ 1980, 281 546-549
15. Mortimer EA, Kimura M, Cherry JD, et al Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tstanus toxoids following household exposure of Japanese children Am J Dis Child 1990, 144. 899-904
16. Bernstein DI, Smith VE, Schiff GM, et al Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age Pediatr Infect Dis J 1993, 12 131-135
17. Centers for Disease Control Pertussis vaccination acellular pertussis vaccine for reinforcing and booster use - supplementary ACIP statement Recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR Morb Mortal Wkly Rep 1992, 41 (No RR-1) 1-10
18. Centers for Disease Control Pertussis vaccination, acellular pertussis vaccine for the fourth and fifth doses of the DTP series, Update to supplementary ACIP statement Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 1992, 41 (No RR-16) 1-5
19. Cherry JD Acellular pertussis vaccine - a solution to the pertussis problem J Infect Dis 1993, 168 21-24
20. Edwards KM, Decker MD Acellular pertussis vaccines for infants N Engl J Med 1996, 334: 391-392
21. Centers for Disease Control Pertussis - United States, January 1992-June 1995 MMWR Morb Mortal Wkly Rep 1995, 44 525-529.